Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials

  • Takao Ohki
  • , Hiroyoshi Yokoi
  • , Kimihiko Kichikawa
  • , Takeshi Kimura
  • , Scott A. Snyder
  • , Anthony O. Ragheb
  • , Erin E. O'Leary
  • , Michael R. Jaff
  • , Gary M. Ansel
  • , Michael D. Dake

Research output: Contribution to journalArticlepeer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Two-year analysis of the Japanese cohort from the Zilver PTX randomized controlled trial supports the validity of multinational clinical trials'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science

Biochemistry, Genetics and Molecular Biology

Keyphrases

Immunology and Microbiology